In conclusion, our present study suggested that MA is not only a potential agent for reducing renal fibrosis by directly targeting TGF-β/Smad signaling, but also an effective inhibitor of MyD88 that may be involved in Smad4 nuclear expression or localization and NF-κB signaling. The gene discussed is NFKB1; the disease is renal fibrosis.